Jack A. Khattar
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2026-08-03–present
-
Current
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Supernus Pharmaceuticals, Inc. (SUPN) | Chief Executive Officer, President & Secretary | $1,036,000 | $15,501,557 |
| 2024 | Supernus Pharmaceuticals, Inc. (SUPN) | Chief Executive Officer, President & Secretary | $1,006,105 | $17,848,004 |
| 2023 | Supernus Pharmaceuticals, Inc. (SUPN) | Chief Executive Officer, President & Secretary | $963,000 | $13,278,093 |
| 2022 | Supernus Pharmaceuticals, Inc. (SUPN) | Chief Executive Officer, President & Secretary | $913,500 | $10,012,717 |
| 2021 | Supernus Pharmaceuticals, Inc. (SUPN) | Chief Executive Officer, President & Secretary Timothy C. Dec Senior Vice President, Chief Financial Officer | $870,000 | $8,116,721 |
| 2020 | Supernus Pharmaceuticals, Inc. (SUPN) | Chief Executive Officer, President & Secretary Timothy C. Dec Senior Vice President, Chief Financial Officer | $836,400 | $6,669,046 |
| 2019 | Supernus Pharmaceuticals, Inc. (SUPN) | Chief Executive Officer, President & Secretary Timothy C. Dec Senior Vice President, Chief Financial Officer | $812,000 | $8,123,132 |
| 2018 | Supernus Pharmaceuticals, Inc. (SUPN) | Chief Executive Officer, President & Secretary | $724,000 | $7,220,419 |
| 2017 | Supernus Pharmaceuticals, Inc. (SUPN) | Chief Executive Officer, President & Secretary | $614,000 | $5,571,674 |
Recent activity
Earnings-call appearances and filed executive appointments or departures, newest first.